In recent years, several studies have focused on this cellular process, demonstrating the release of EVs following P2X7 stimulation from different cancer types, such as neuroblastoma [131,134], lung [131], prostate [135], breast cancers [131,136], and also melanoma [43,58]. Here, P2RX7 is linked to neuroblastoma.